Identification of Eupatilin from Artemisia argyi as a Selective PPARα Agonist Using Affinity Selection Ultrafiltration LC-MS

Peroxisome proliferator-activated receptors (PPARs) are key nuclear receptors and therapeutic targets for the treatment of metabolic diseases through the regulation of insulin resistance, diabetes, and dyslipidemia. Although a few drugs that target PPARs have been approved, more diverse and novel PPAR ligands are necessary to improve the safety and efficacy of available drugs. To expedite the search for new natural agonists of PPARs, we developed a screening assay based on ultrafiltration liquid chromatography-mass spectrometry (LC-MS) that is compatible with complex samples such as dietary foods or botanical extracts. The known PPARα and/or PPARγ ligands resveratrol and rosiglitazone were used as positive controls to validate the developed method. When applied to the screening of an Artemisia argyi extract, eupatilin was identified as a selective PPARα ligand. A PPAR competitive binding assay based on FRET detection also confirmed eupatilin as a selective PPARα agonist exhibiting a binding affinity of 1.18 μM (IC50). Furthermore, eupatilin activation of the transcriptional activity of PPARα was confirmed using a cell-based transactivation assay. Thus, ultrafiltration LC-MS is a suitable assay for the identification of PPAR ligands in complex matrixes such as extracts of dietary foods and botanicals.

[1]  Kewu Zeng,et al.  Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  C. Bala,et al.  Surface Plasmon Resonance (SPR) Biosensors in Pharmaceutical Analysis , 2015, Critical reviews in analytical chemistry.

[3]  W. Hsu,et al.  A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia. , 2013, Toxicology and applied pharmacology.

[4]  M. Rhee,et al.  Anti-inflammatory activities and mechanisms of Artemisia asiatica ethanol extract. , 2014, Journal of ethnopharmacology.

[5]  T. Ochiya,et al.  DSE-FRET: A new anticancer drug screening assay for DNA binding proteins , 2014, Cancer science.

[6]  W. Price,et al.  A fragmentation study of isoflavones in negative electrospray ionization by MSn ion trap mass spectrometry and triple quadrupole mass spectrometry. , 2007, Rapid communications in mass spectrometry : RCM.

[7]  D. Ribnicky,et al.  Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture , 2014, Diabetes, obesity & metabolism.

[8]  Juan J. Marugan,et al.  A High Throughput Screening Assay System for the Identification of Small Molecule Inhibitors of gsp , 2014, PloS one.

[9]  Q. Shi,et al.  PPARγ agonist from Chromolaena odorata. , 2012, Journal of natural products.

[10]  Karim Benkirane,et al.  Vascular and Cardiac Effects in Hypertension , 2022 .

[11]  B. Spiegelman,et al.  International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors , 2006, Pharmacological Reviews.

[12]  William Fenical,et al.  Screening natural products for inhibitors of quinone reductase-2 using ultrafiltration LC-MS. , 2011, Analytical chemistry.

[13]  K. Hahm,et al.  The Anti-inflammatory Effects of Acidic Polysaccharide from Artemisia capillaris on Helicobacter pylori Infection , 2013, Journal of cancer prevention.

[14]  D. Ribnicky,et al.  An Extract of Artemisia dracunculus L. Inhibits Ubiquitin-Proteasome Activity and Preserves Skeletal Muscle Mass in a Murine Model of Diabetes , 2013, PloS one.

[15]  Nathan R. Qi,et al.  Insulin Resistance and Metabolic Derangements in Obese Mice Are Ameliorated by a Novel Peroxisome Proliferator-activated Receptor γ-sparing Thiazolidinedione* , 2012, The Journal of Biological Chemistry.

[16]  S. Noha,et al.  Honokiol: A non-adipogenic PPARγ agonist from nature☆ , 2013, Biochimica et biophysica acta.

[17]  Richard B. van Breemen,et al.  Screening for Ligands of Human Retinoid X Receptor-α Using Ultrafiltration Mass Spectrometry , 2007 .

[18]  P. Forgó,et al.  Antiproliferative Activity of Artemisia asiatica Extract and Its Constituents on Human Tumor Cell Lines , 2014, Planta Medica.

[19]  J. Bouajila,et al.  Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L. and Peganum harmala L. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[21]  J. Bolton,et al.  Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors , 2005, Journal of the American Society for Mass Spectrometry.

[22]  D. Ribnicky,et al.  Bioactives of Artemisia dracunculus L. Mitigate the Role of Ceramides in Attenuating Insulin Signaling in Rat Skeletal Muscle Cells , 2012, Diabetes.

[23]  I. W. Nilsen,et al.  Efficient Screening of Marine Extracts for Protease Inhibitors by Combining FRET Based Activity Assays and Surface Plasmon Resonance Spectroscopy Based Binding Assays , 2013, Marine drugs.

[24]  G. Massolini,et al.  Resveratrol and Its Metabolites Bind to PPARs , 2014, Chembiochem : a European journal of chemical biology.

[25]  H. Kwon,et al.  Anti-diabetic effect of amorphastilbol through PPARα/γ dual activation in db/db mice. , 2013, Biochemical and biophysical research communications.

[26]  Tian Zhu,et al.  High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes , 2013, PloS one.

[27]  R. V. van Breemen,et al.  Development of a screening assay for ligands to the estrogen receptor based on magnetic microparticles and LC-MS. , 2008, Combinatorial chemistry & high throughput screening.

[28]  Kyeong Lee1,et al.  A Peroxisome Proliferator-Activated Receptor-gamma Agonist and Other Constituents from Chromolaena odorata , 2009, Planta medica.

[29]  Noeris K. Salam,et al.  Novel PPAR‐gamma Agonists Identified from a Natural Product Library: A Virtual Screening, Induced‐Fit Docking and Biological Assay Study , 2007, Chemical biology & drug design.

[30]  L. J. Hardies,et al.  Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus , 2007, Diabetologia.

[31]  B. Staels,et al.  Inflammation, dyslipidaemia, diabetes and PPARs: pharmacological interest of dual PPARα and PPARγ agonists , 2004 .

[32]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[33]  G. Firestone,et al.  Artemisinin Blocks Prostate Cancer Growth and Cell Cycle Progression by Disrupting Sp1 Interactions with the Cyclin-dependent Kinase-4 (CDK4) Promoter and Inhibiting CDK4 Gene Expression* , 2009, Journal of Biological Chemistry.